INTRODUCTION
The vertebrate heart is formed in vivo as a linear tube of so-called primary myocardium.
At embryonic day (E)8.25 chamber formation is initiated, accompanied by expression of atrial natriuretic factor (Anf) mRNA in the ventricles and the atria (Christoffels et al. 2000) . Differentiation of embryonic stem (ES) cells to the cardiac lineage provides an important model to investigate mechanisms and genes involved in the earliest steps of cardiac development (Boheler et al. 2002) . Moreover, production of cardiomyocytes in an in vitro system offers a potentially unlimited source of donor material for grafting therapies (Klug et al. 1996) . Both applications of the ES cell differentiation model require proper characterisation of the formed heart cells. A developmental in vivo standard enables discrimination between the initial primary myocardial cells and later developing ventricular and atrial chamber myocytes.
It is the focus of many research groups to analyse how in vitro differentiation of ES cells relates to in vivo cardiogenesis. Besides an inventory of gene expression in ES cellderived cardiomyocytes, these studies often include electrophysiological characteristics. In these studies the expression of myosin light chain (Mlc)2v (Lyons et al. 1995; Guan et al. 1999; Miller-Hance et al. 1993; Doevendans et al. 2000; Muller et al. 2001; Klug et al. 1996; Fussier et al. 1996; Meyer et al. 2000) , Anf (Fassler et al. 1996; Guan et al. 1999) and Mlc2a mRNA (Klug et al. 1996; Meyer et al. 2000) has been used to ascribe a ventricular or atrial phenotype to ES cell-derived cardiomy-ocytes. A confusing factor in these studies is that, although these genes are confined to their nominal compartments in the heart after birth (O 'Brien et al. 1993; Kubalak et al. 1994) , none of them is restricted to these compartments at the early embryonic stages (before El3). Moreover, quantitative data are scarce. An additional complicating factor is the scarcity of in vivo electrophysiological data on mouse cardiac development that can be used as a standard to characterise ES cell-derived cardiomyocytes. In the present study we assessed the expression of a number of cardiac genes among those that have been used in ES cell studies to define the phenotypes of ES cell-derived cardiomyocytes to analyse the progress of cardiac differentiation. We performed a cjuantitative and qualitative comparison between ES cell-derived cardiomyocytes and cardiomyocytes derived from embryonic mice, based on in situ hybridisation (ISH), quantitative reverse transcription (RT)-PCR and electrophysiology. The characteristics of the ES cell-derived cardiomyocytes are largely similar to those observed in embryonic cardiomyocytes at E8.75-9. We conclude that the development of ES cell-derived cardiomyocytes includes hardly any formation ot chamber myocardium and therefore does not significantly progress bey r ond that of cardiomyocytes of the embryonic heart tube stage in vivo. Tnni3 (cardiac troponin I).
METHODS

Mouse
Cell Culturing, Animals and Tissue Preparation
Culturing of undifferentiated mouse ES cells of the line HM1 (Magin et al. 1992 ) was performed as described before . Cardiac differentiation was evoked by culturing the cells in aggregates called embryoid bodies (EBs), using the hanging drop assay essentially as described by Maltsev et al. (1994) 
Myocyte isolation for ekctropbysio/ogy
Isolation of cardiomyocytes from EBs was performed as described by Maltsev et al. (1994) . Myocytes from El2.5 mouse hearts were prepared as follows. Pregnant mice were killed by cervical dislocation. The uterus was quickly dissected, rinsed once with Tyrode's solution 1, containing in mM: NaCl 135.1, NaHCCV, 4.3, KC1 4.7, CaCl 2 2.6, MgCl 2 2.0, glucose 11 and HEPES 16.8 (pH was adjusted to 7.3 with NaOH), opened, and the exposed embryos were decapitated. The hearts of the embryos were dissected and separated into three parts: right+left atrium, apical part of the left ventricle, and outflow tract, collected in Eppendorf tubes and rinsed once with ice-cold Tyrode's solution 1.
This solution was replaced by dissociation buffer, consisting of Tyrode's solution 1 from which CaCb was omitted and 1 mg/ml collagenasc B (Roche; Mannheim, Germany) was added, and incubated at 37°C for 30 minutes. Every 10 minutes the tissue was gently triturated for 3 seconds until the tissue was dissociated into single cells and small clusters.
Cells and clusters were allowed overnight to adhere to 3-aminopropyltriethoxisilanecoated coverslips before being used the next day.
Tissue processing for histology
For preparation for ISH and immunohistochemistry, beating EBs were harvested from suspension culture, rinsed twice in PBS and fixed in 4% formaldehyde in PBS for 30 minutes at RT. Groups of EBs were embedded in 1% sterile agarose (ultraPURE TM ,BRL, 5510UB) in PBS at 50°C and stored in 70% ethanol at 4°C until further treatment.
Agarose blocks were dehydrated in a graded ethanol series and butanol, and embedded in paraplast. For preparation for ISH on sections, embryos were fixed for 4-16 hours in freshly prepared 4% formaldehyde in phosphate buffered saline (PBS, 150mM NaCl, lOmM Na-phosphate, pH 7.4) by rocking at 4°C . Embryos were dehydrated in a graded ethanol series and in butanol, and embedded in paraplast.
Serial sections of 15 |Im of EBs and embryos were mounted onto microscope slides coated with 3-aminopropvltriethoxysilane.
Non-Radioactive In Situ Hybridisation
Digoxigenin-labeled probes were made according to the manufacturers specifications, using Dig-UTP (Roche; Mannheim, Germany). Isoform-specific probes were used complementary to the mRNA coding for cardiac Troponin I (cTnl) (Ausoni et al. 1991) , 'Brien et al. 1993) , Anf (Seidman et al. 1984 ), Mlc2a (Kubalak et al 1994 , sarcoendoplasmic reticulum calcium ATPase (Serca)2 (Moorman et al. 1995) and (Xmyosin heavy chain (OcMhc) (Boheler et al. 1992) . Moorman et al. 2001 ). Because of low RNA expression levels in ES cell-derived cardiomyocytes, the signal detection of hybridisation on sections of EBs was enhanced using a tyramide-mediated amplification kit (NEN, Boston). Expression patterns were studied in EBs derived from several independent differentiation experiments at time points between 4 and 35 days of differentiation in floating cultures. Independent experiments showed similar patterns.
Primer design, Reverse transcription and Real-time Polymerase Chain Reaction
Complementary DNA PCR primers for mouse were designed using Oligo primer analysis (version 4.1, National Biosciences) and Primer Express (version 1.0, PE Applied Biosystems) software from DNA and RNA sequences obtained from GenBank (Table 1) .
Al primer sets had a calculated annealing temperature of 58°C (nearest neighbour method). The sense primer for Na + /Ca 2+ exchanger (Ncx)l was designed in a cardiacspecific part of the transcript (Kofuji et al. 1994) . Primers were obtained from Biolegio (The Netherlands).
First-strand complementary DNA was synthesized from 1 (Ig total RNA as described by priming with a mixture of 2 pmol gene-specific reverse and 125 pmol oligo-dTnvN primer (Biolegio, The Netherlands) in a total volume of 25 (4.1.
For each sample two separate cDNA synthesis reactions were performed.
Quantitative RT-PCR was performed as described (Lekanne using the fluorescent dye SYBR green I, the Light Cycler Instrument (Roche) and software version 3.0 (Roche). Absolute copy numbers were estimated using standard curves made from dilution series of amplicon sequence solutions of known concentration (Lekanne . Approximate average mRNA copy numbers per cell were calculated assuming a 1:1 relationship between RNA and cDNA molecules made during reverse transcription, and that each cell contains the same total amount, 45pg (Alberts et al. 1994 ), of RNA. 18S expression levels were used to correct for variations in RNA input.
Results are expressed as mean ± standard deviation.
Differences in gene expression between time points were tested with a one-way
ANOVA. The Student-Newman-Keuls test was used to determine homogenous subsets of time points per gene. To determine equivalence of in vitro and in vivo expression levels, per pair of in vitro and in vivo time points the squared difference of the values per gene was calculated and summed for all genes. The combination of time points with the least squared difference was considered the combination at which the gene expression patterns in vitro and in vivo correlated best. To avoid undue influence of differences in expression level between genes (a 10000 times difference between Mlc2v and cTnl mRNA was observed) the logarithms of the values were used in this calculation. Statistics was performed using SPSS (SPSS Inc. version 11.0.1).
Electrophysiology
Coverslips containing the attached differentiated ES cells were mounted in a chamber on the stage of an inverted microscope (Nikon Diaphot) and superfused at a rate of approximately 1 ml/min with Tyrode's solution 2 of 33-35°C, containing in mM: NaCl 140, KC1 5.4, CaCl 2 1.8, MgCl 2 1.0, glucose 5.5 and HEPES 5.0 (pH set at 7.4 with NaOH). Action potentials (APs) and membrane currents were recorded using whole-cell patch clamp, digitised at 2-10 kHz and stored on the hard disk of a computer (Apple Macintosh Quadra 650), equipped with a data-acquisition board (National Instruments).
Recording pipettes had resistances of 5-10 MOhm when filled with a solution containing in mM: K-gluconate 140, KC1 10, HEPES 5.0 (pH set at 7.2 with KOH). Series resistance was compensated for 60-80%.
From spontaneous and stimulated APs the following parameters were measured: AP amplitude (APA), maximum diastolic potential (MDP), upstroke velocity (K max ), AP duration (APD) at 20, 50 and 80% repolarisation and spontaneous interval. Of each recording the parameters of at least 5 APs were averaged.
In voltage-clamp, calcium current (/ (aI ) was measured in a series of 500 ms clamp steps ranging from -100 to +60 mV, increment 10 mV, interval 5 seconds. Holding potential (l^hoid) was ~^0 mV to inactivate fast sodium currents. The difference between maximum inward peak and current at the end of the steps was taken as the amplitude of 7 C j. Similarly, the amplitude of the fast sodium current 7 Na was taken as the difference between inward current peak and steady state current recorded during steps from a V hold of -80 mV. The change in slope during current pulses, applied in current clamp was used to calculate membrane capacitance C m using C m = I/dV/dt. Membrane currents were expressed as current densities by dividing I m through C m . Data are expressed as mean ± S.E.M., ANOVA on each electrophysiological parameter was used for testing differences between differentiation stages. Cluster analysis (SPSS, version 11.0.1) was used to divide ES cell data into homogeneous subgroups (Fig. 6D ).
Immunohistochemistry
Mounted sections were deparaffinated and hydrated in xylene and a graded series of ethanol, and washed in PBS. Sections were incubated in 0. 
RESULTS
The aggregation of ES cells into EBs appears to be the trigger for differentiation towards a plethora of phenotypes (Guan et al. 1999) , including beating cardiomyocytes. After at least 2 days in a floating culture, contractions were observed indicating the presence of cardiomyocytes. After 4 days in a floating culture up to 96% of the EBs shows vigorous beating activity throughout the entire EB, owing to an approximately 30% cardiomvocyte content (unpublished data).
Gene expression patterns
To define whether cTnl mRNA expression can be used as a marker for all cardiomyocytes in EBs, the in vivo pattern of expression in the mouse heart was analysed. In Xenopus (Drysdale et al. 1994 ) and chicken (Houweling et al. 2002) cTnl mRNA expression marks specifically all cardiomyocytes from early stages onward. In rat, cTnl mRNA is expressed in the embryonic heart as well (Ausoni et al. 1991) . Ubiquitous expression was observed in the chamber myocardium of the atria and ventricles, and in the primary myocardium of the atrioventricular canal ( Fig. 1A ) and outflow tract (not shown) of a E9.5 mouse heart. cTnl mRNA expression was found to be restricted to the myocardium. In vitro, cTnl mRNA expression colocalises with Serca2a, another gene expressed in all cardiomyocytes in vivo (Anger et al. 1994 mRNA expression became restricted to a part of the cardiomyocyte area ( Fig. 2G ).
Comparison of expression areas of cTnl and Mlc2v mRNAs was substantiated in 4
independent differentiation experiments in time and significantly fitted a line predicted by a logistic regression model (Fig. 3) . In vivo, Mlc2v mRNA is also expressed in a subset of cardiomyocytes. Figure IB shows expression of Mlc2v mRNA at E9.5 in the atrioventricular canal and the embryonic ventricle but not in the atria. Anf mRNA expression was hardly detectable in EBs. From 78 EB sections stained with the Anf probe 63 did not show any signal and 1 5 showed a few very weak positive spots (Fig. 2H) not found in the controls without probe. Figure 1C shows that in embryonic hearts Anf mRNA is expressed in the developing atrial and ventricular chambers but not in the atrioventricular canal. 
Gene expression levels
Cardiac gene expression in vivo increased with development for most genes investigated ( Fig. 4A ). Levels of Mlc2v and Anf mRNA were low until E9, and then increased significandy (P<0.05) till El 5 to stay at a variable high level until adulthood (one-way ANOVA, homogeneous subsets E7.5-9 and E15-adult). Early embryonic cTnl mRNA expression was relatively low, showed a perinatal increase and is low again at adulthood.
Ncxl mRNA expression significantly increased until E9 and decreased after birth, whereas Serca2a mRNA levels gradually but significandy rose during embryonic and postnatal life.
Observations in EBs were based on two independent differentiation experiments.
Both time course experiments showed a significant time-dependent effect on gene expression profiles with a similar trend, although peaks in expression varied a few days between the independent experiments (P<0.01; two-way AN OVA on log-trans formed data). Developmental profiles of one experiment are given in Figure 4B . Expression levels of the investigated mRNAs showed an increase within 14 days of culture in which each time point differed significantly from the previous point (P<0.05; one-way ANOVA). Mlc2v and Ncxl mRNA expression peaked at 10, cTnl and Serca2a at 14 and Ant at 17 days of culture. Levels decreased to a plateau at 17-21 days and were low again at 25 days of differentiation. Expression levels at day 3+4 to 3+25 in vitro correlated best with levels as observed in the embryonic heart in vivo at E8.75-9 (least squared distance).
EBs that were differentiated in attachment cultures showed expression levels similar to 15001 «1000' . Levels are expressed in molecules per cell, assuming that a 1:1 relationship between RNA and cDNA molecules made during reverse transcription exists, and that each cell contains the same total amount, 45pg (Alberts et at. 1994) , of RNA. In vivo Mlc2v mRNA copies per cell are indicated on the right y-axis of Figure 4A. E8.5-8.75 (Fig. 4C ). Anf mRNA expression in EBs is very low and at day 3+25 to 3+30 fluctuates between 1.1 and 5.1 population-averaged molecules per cell in floating as well as in attached cultures. This argues against a potential stimulating effect of attachment cultures on differentiation to chamber-type cardiomyocytes.
Electrophysiology
Action potential characteristics from ES cell-derived cardiomyocytes
During the differentiation period a variety of action potential shapes could be recorded, including those reported by Hescheler et al. (1997) . Figure 5A shows that early during differentiation (3+7 days) action potentials can be recorded with a relatively long duration (APD) and a slow upstroke (Kmax), while later during differentiation slow 'pacemaker-like' APs were still found, but average action potentials tended to be shorter while having a higher Kmax (Fig. 5A, lower right) .
For comparison with the other results presented in this paper, we determined average action potential characteristics during the differentiation process. We determined the action potential durations APD20, APD50 and APDso, upstroke velocity (K ma x), maximal diastolic potential (MDP) and the spontaneous interval at various stages of differentiation. Figure 5B shows that during differentiation the average action potential shortened considerably (P<0.0001; ANOVA), while K max (Fig. 5C ) increased (P<0.001; ANOVA). Due to the variety of action potential configurations, a large scatter was observed especially in K ma x at day 3+10 and later. During differentiation, no significant increase of the negative MDP was observed (P=0.5; ANOVA), (Fig. 5D ). The spontaneous beating interval decreased (P<0.0001; ANOVA), as shown in Figure 5E . Averaged maxima of /c a ,i. and Z\ a current densities were plotted against time of differentiation in Figure 5F . This figure illustrates that 7x a increased in time of differentiation (P=0.01; ANOVA). No significant increase in ic a ,i. was detected (P=0.4; ANOVA).
Comparison with action potential characteristics from embryonic cardiomyocytes
To assess the electrical maturation of the ES cell-derived cardiomyocytes we compared their electrical properties with those of El 2.5 myocytes. Action potentials of cells or small cell clusters from the 3 compartments showed characteristics that were clearly distinct from each other. Figure 6A shows representative examples of action potentials recorded from atrial, ventricular and outflow tract myocytes. Figure 6B and C show the average properties of APD 50 and V max respectively. Vttux and APD50 differed significantly (P<0.03; ANOVA) for all compartments, except for the APD50 from OFT and ventricular cells (P=0.18; ANOVA). Compared to cells from other regions, atrial cells exhibited a high upstroke velocity (>100 V/s) and a relatively short APD 50 that did not show a large dependence on stimulus frequency. Outflow tract cells had an APD50 comparable with that of ventricular cells, but showed a considerably lower V aaaL than that found in the other regions. Both outflow tract and ventricular cells showed a negative frequency dependence of the APD 50 . We compared these 3 cell types with ES cell-derived cardiomyocytes in a plot of K max versus APD, wherein the average data of the embryonic cardiomyocytes are plotted together with those from the individual ES cell-derived cardiomyocytes (Fig. 6D ). Cluster analysis indicated that the ES cell data formed 3 groups:
(1) high K max , short APD, (2) low K max , short APD and (3) low F max , long APD). In this panel the ES cell-data are grouped in 'early' and 'late', illustrating that a combination of a low 1/max and a long APD is usually found early in differentiation, while at later stages more short APs with high I ' max are found. Comparison with the embryonic heart data showed that ES cell-derived cardiomyocytes from group 2 and 3 did not significantly differ from cells from the outflow tract {i.e. primary myocardium (Moorman and Christoffels, 2003) ). ES cell-derived cardiomyocytes from group 1 with a high V ma3 , and a short APD, as found more often late during differentiation, differed not significantly from the embryonic atrial myocyte. The ventricular parameters differed significantly from all three ES groups (P<0.01; bivariate ANOVA). Figure 6 . Electrical properties of El 2.5 cardiomyocytes isolated from distinct compartments. (A) Representative APs from El 2.5 mouse atrial (n=9), ventricular (n=12) and outflow tract (n=9) myocytes. (B) Frequency response of APD50. (C) Frequency response of l^max-Note the lower I^max of the outflow tract cells, compared with that of cells from the other compartments and the shorter APD50 in atrium, compared to that of cells from the other compartments. (D) IS max vs APD511 of individual ES cell-derived cardiomyocytes early (3+4 to 3+10) and late (3+14 to 3+22) during differentiation, related to average Vmxs. vs APD50 of myocytes from atrial, outflow tract and ventricular origin stimulated at 2 Hz. Numbers 1-3 refer to statistically different separate groups of ES cell-derived cardiomyocytes as indicated by cluster analysis.
DISCUSSION
Gene expression and electrophysiological data reveal the characteristics of ES cell-derived cardiomyocytes to resemble those of cardiomyocytes from earlier stages of myocardial development than previous authors have concluded from expression of similar genes (Miller-Hance et al. 1993; Muller et al. 2001; Meyer et al. 2000; Lyons et al, 1995; Guan et al. 1999; Hescheler et al. 1997; Doevendans et al. 2000; Klug et al. 1996; Fassler et al. 1996; Kubalak et al. 1994) . The difference is possibly due to the fact that in this study compared to others a different combination of genes is used, expression levels were quantified and early embryonic expression patterns were taken into consideration instead of adult/late embryonic patterns to define certain genes as markers of myocardial phenotypes.
Expression patterns
The expression patterns of several genes in the heart change with development. Many genes have a broader pattern of expression in the embryonic period than in the adult.
Mlc2v mRNA expression is shown in the atrioventricular canal, the embryonic ventricle and also in the proximal outflow tract (O 'Brien et al. 1993) , i.e. more broadly than in the ventricle alone as found in the adult. Mlc2v mRNA is selectively expressed in a subset of cardiac myocytes from E7.5 onwards (Lyons et al. 1995) long before ventricular chamber cells are formed. Furthermore, Mlc2v mRNA is also expressed in cells that will not become ventricle but the lower parts of the atrial chambers and the atrioventricular node (Moorman and Christoffels, 2003) . Therefore, the expression of Mlc2v mRNA does not indicate the formation of ventricular cells during cardiogenesis in vivo and in vitro per se.
At E8.5 Mlc2a and OCMhc mRNA are expressed along the entire heart tube in a gradient decreasing towards the downstream part of the heart tube. Because these genes become first confined to the atrial compartment in late embryonic life (from c. P. 13 onwards) (Kubalak et al. 1994; Lyons et al. 1990 ) they can only be used as a general myocardial marker in a culture of differentiating cardiomyocytes. Anf is another gene sometimes incorrectly used when applied as a marker to identify putative atrial cells in ES cell cultures (Fassler et al. 1996; Guan et al. 1999) . Anf mRNA is observed in the developing chamber myocardium of the future atrial appendages and in the ventricular trabeculations that will contribute to the peripheral ventricular conduction system ) but not in the primary myocardium of the atrioventricular canal, the inflow tract, and the outflow tract (the latter two not visible in Fig. 1C ) (Christoffels et al. 2000) .
Therefore, Anf mRNA expression is used by us as a marker for developing chamber myocardial cells in vitro.
Expression levels
In general, we found very low expression levels that were most similar to those observed in the early embryonic heart at E8.75-9. For cTnl mRNA, a developmental increase has been described at late embryonic stages (Ausoni et al. 1991) This early appearance is in contrast with other studies (Guan et al. 1999; Kubalak et al. 1994; Miller-Hance et al. 1993; Hescheler et al. 1997; Doevendans et al. 2000) in which the delayed expression of Mlc2v mRNA may have led to the idea that Mlc2v gene expression is indicative of development of ventricular working myocardium.
For the embryonic period, quantitative data on Ncxl and Serca2a mRNAs in mice are lacking. Similar to our observations, Ncxl mRNA content has been reported to decrease around birth (Koban et al. 1998) . Serca2a mRNA has been reported to be present from E9 onward in rat (Moorman et al. 1995 ) (-mouse E7.0), and a functional sarcoendoplasmic reticulum develops with chamber formation (Nakanishi et al. 1987) .
The increase in the levels of Serca2a mRNA during development is in line with earlier studies but these did not encompass the early embryonic period (before El3) (Ribadeau-Dumasf/ö/. 1999; Lompré et al. 1991) .
Anf mRNA levels increase from E8.25 onwards when formation of working myocardium is initiated (Christoffels et al. 2000) . Expression peaks in adulthood, where it is abundantly expressed in the atria (Zeiler et al. 1987 ) and only very weakly in the peripheral conduction system of the ventricles (Moorman and Christoffels, 2003) . In vitro, the average Anf mRNA expression was found at levels approximately 100 fold lower then those observed in adult myocardium. This difference is actually much higher because of the preferential expression of Anf mRNA in the adult atria. Anf mRNA expression in differentiating EB cultures has been reported (Kubalak et al. 1994; Miller-Hance et al. 1993; Hescheler et al. 1997; Fassler et al. 1996) , but quantitative data are lacking.
It is not known to what extent the in vivo cardiogenic pathway is recapitulated during ES cell differentiation in vitro. However, undifferentiated ES cells would have to go through a process of differentiation to reach a phenotype reminiscent of that of adult myocytes. In defining this, the use of in vivo gene expression patterns as a developmental marker can be justified.
Electrophysiology
The electrophysiological experiments showed that on average during differentiation of ES cell-derived cardiomyocytes the APD and the beating interval decreases whereas V mix increases. Some of these changes are similar to those seen during in vivo development of the murine ventricle. Initially at E9.5, ventricular cells have a relatively low l^m ax and an APD 50 of 100-200 ms. At El 8, K max increases and the APD shortens to 74 ms (Liu et al. 1999; Yasui et al. 2001) and at 3 neonatal days, APD.so shortens even further to 18 ms (Wang et al. 1996) . Other changes are different from the in vivo observations. At E9.5 ventricular cells beat spontaneously with a regular interval of about 1 s, whereas from
El8 onward the cells become silent at a negative resting potential (Yasui et al. 2001) . We showed that the average beating interval of ES cell-derived cardiomyocytes decreased in time. This suggests that most ES cell-derived cardiomyocytes do not develop into a ventricular phenotype, but towards a nodal phenotype, which mostly resembles primary myocardium (Moorman and Christoffels, 2003) .
Our observation that I Xa increases during in vitro differentiation agrees well with the findings of Maltsev et al. (1994) and indicates that this increase is involved in the increase in Kmax as observed during differentiation.
CONCLUSION
ES cell-derived cardiomyocytes are not differentiated towards fully mature chamber myocardium as yet. They rather show a phenotype comparable to young embryonic cardiomyocytes in vivo. Several arguments support this interpretation. Firstly, expression levels of genes in differentiating ES cell cultures are similar to levels observed in the primary heart tube stage at E8.75-9. Secondly, markers that are chamber-specific in the late embryonic and adult heart (aMbc and Mlc2a) (Kubalak et al. 1994; Lyons et al. 1990) , and the general cardiac markers cTnl and Serca2a (Ausoni et al. 1991; Anger et al. 1994) showed expression in the entire myocardial area of the EB. These observations indicate that at the level of regulation of Mlc2a and (XMhc the distinction between a primary or a chamber phenotype has not been made. Thirdly, Anf, the only currently known gene that is exclusively expressed in the forming atrial and ventricular chambers (Christoffels et al. 2000) , is expressed at very low levels in differentiating EBs, indicating that hardly any chamber myocardium has developed. Fourthly, electrophysiological properties of early ES cell-derived cardiomyocytes were most reminiscent of cells from the outflow tract and further differentiation resulted in cells comparable to those of the embryonic atrium.
However, it has to be assessed whether the atrial electrophysiological characteristics are also represented in the embryonic heart tube and as such would represent normal variation of cardiomyocytes in this stage of heart development. Finally, all cardiomyocytes analysed by patch clamp showed automaticity, a characteristic for all embryonic cardiomyocytes and for nodal cells in the mature heart.
Taken together, the levels of expression of several key cardiac genes and electrophysiological features strongly suggest that the phenotypes of cardiomyocytes in differentiating EBs are most reminiscent of cardiomyocytes from E8.75-9 mouse hearts where chamber formation has just started. However, the propensity of increasing upstroke velocity of action potentials at later differentiation times could indicate that a first step towards more mature working myocardium has been made. It will be challenging to induce further differentiation of chamber myocardium in vitro and unravel the underlying process using this culture system.
